Multiple Sclerosis Drug Approval Tops SPT Most Read Articles of the Week


Top five most popular articles this week on Specialty Pharmacy Times.

5. Long-Awaited Multiple Sclerosis Drug Wins FDA Approval

Ocrelizumab (Ocrevus) granted FDA approval to treat 2 forms of MS.

4. Rheumatoid Arthritis Drug Market Will Reach Nearly $30 Billion by 2025

New report reveals trends in the 8 major markets over the next decade.

3. Dupilumab FDA Approved for Treatment of Atopic Dermatitis

Injection helps clear skin and manage itch severity caused by the disease.

2. Four Reasons Why Specialty Pharmacies Fail

There is little room for error in the highly competitive specialty pharmacy landscape.


Ocrelizumab Approval to Shift Multiple Sclerosis Treatment Landscape

Neurologist Michael Racke, MD, discusses the new FDA approval of ocrelizumab and how it will impact the future treatment of MS.

Related Videos
Image credit:  Chanintorn.v | - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
Image credit: сергей костюченко | - human head with brain
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa |
Image Credit: SciePro -
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 -
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская |
© 2024 MJH Life Sciences

All rights reserved.